A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells
(Q39943622)
scientific article published on 9 October 2008
scientific article published on 9 October 2008
Language: